COVID-19
infectie na immunisatie
||
aandoening door infectie met 'Severe acute respiratory syndrome'-coronavirus 2 na vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 (aandoening)
COVID-19 na vaccinatie tegen SARS-CoV-2
aandoening door infectie met 'Severe acute respiratory syndrome'-coronavirus 2 na vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2
COVID-19 na toediening van vaccin tegen SARS-CoV-2
aandoening door infectie met SARS-CoV-2 na vaccinatie tegen SARS-CoV-2
aandoening door infectie met SARS-coronavirus 2 na actieve immunisatie tegen SARS-coronavirus 2
SARS-CoV-2 breakthrough infection
Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2
COVID-19 breakthrough infection
Severe acute respiratory syndrome coronavirus 2 breakthrough infection
Id1217296006
StatusDefined
Aftervaccinatie tegen SARS-CoV-2
Causative agentSARS-CoV-2
Pathological processinfectieus proces
SNOMED CT to ICD-10 extended map
TargetU07.1
RuleTRUE
AdviceALWAYS U07.1 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified
TargetT88.0
RuleTRUE
AdviceALWAYS T88.0 | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE
CorrelationSNOMED CT source code to target map code correlation not specified
TargetU12.9
RuleTRUE
AdviceALWAYS U12.9
CorrelationSNOMED CT source code to target map code correlation not specified